General Biologicals Corporation (4117.TWO) Key Statistics
$6.45TWO: 4117.TWOMarket Cap $598.19M
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for General Biologicals Corporation (4117.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
1.00
P/B ratioShare price divided by book value per share.
0.75
P/S ratioMarket value divided by annual revenue.
2.30
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-44.43
EV / RevenueEnterprise value against annual revenue.
9.71
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
99.88%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
35.40%
Operating marginRevenue left after operating costs.
-27.78%
Net marginRevenue left after every cost, including tax and interest.
199.43%
Return on equityProfit as a percentage of shareholders’ equity.
108.50%
Return on assetsProfit as a percentage of total assets.
-2.08%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.57
Quick ratioThe same, excluding inventory.
1.39
Debt to equityTotal borrowings against shareholders’ equity.
3.17
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$8.44
Book value per shareShareholders’ equity divided by shares outstanding.
$11.25
Shares outstandingShares currently issued.
70,792,000
Market capitalisationShare price times shares outstanding.
$598.19M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
200
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
General Biologicals Corporation (4117.TWO) statistics — frequently asked questions
What is General Biologicals Corporation's P/E ratio?
General Biologicals Corporation (4117.TWO) trades on a price-to-earnings ratio of 1.00.
What is General Biologicals Corporation's return on equity?
General Biologicals Corporation (4117.TWO) reports a return on equity of 108.50%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does General Biologicals Corporation carry?
General Biologicals Corporation (4117.TWO) has a debt-to-equity ratio of 3.17, which compares total borrowings with shareholders' equity.
What is General Biologicals Corporation's profit margin?
General Biologicals Corporation (4117.TWO) keeps 199.43% of revenue as net profit after every cost, including tax and interest.